Latest articles
No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.
Sentiment statistics ?
Financial Histories
Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.
Overview
IONSDay performance
IONS | |
---|---|
Price | 49.83 |
Change Pct | 0.50 |
Change Abs | 0.25 |
Market Cap | 7.1 billion |
Eps | -2.87 |
Pe Ratio | -17.36 |
Outstanding Shares | 143.5 million |
Volume | 240102 |
Avg Volume | 1.1 million |
Industry | Biotechnology |
Sector Name | Health Care |
Country Short Name | US |
Announcement Earnings | 2024-02-20 13:30:00+00:00 |
Dividends
There is no dividend data to display. Refer our Dividend calendar for other accurate data.
Risk Profiles
Please sign up and become a member to view all risk profiles.
Peers
Focus
Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.
Company descriptions
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults;